Nuvation Bio Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Name: Nuvation Bio Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Nuvation Bio Inc - Ordinary Shares - Class A
Rating: 1.48200
Author: Trendlyne DVM scores

about

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-g...

2.24 -0.06 (-2.61%)

35.26% Fall from 52W High

3.7M

XNYS Volume

XNYS 11 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

12.0 / 100

Technically Neutral

47.3 / 100

1Yr Price target upside is 235%

6 analysts

Nuvation Bio Inc - Ordinar... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Nuvation Bio Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-g...

35.26% Fall from 52W High

SWOT Analysis

Nuvation Bio Inc - Ordinar... Live Price Chart